Mol Genet Genomic Med
September 2022
Purpose: To expand the mutation spectrum of patients with familial exudative vitreoretinopathy (FEVR) disease.
Participants: 74 probands (53 families and 21 sporadic probands) with familial exudative vitreoretinopathy (FEVR) disease and their available family members (n = 188) were recruited for sequencing.
Methods: Panel-based targeted screening was performed on all subjects.